OPKO Health, Inc.OPK stock score: 33/100

$1.61 · -4.73% · Scored Nov 19, 2026

Technical
49
Fundamental
29
News
57

The reading

OPKO Health (OPK) scores 33 out of 100, which reads bearish, higher than 7% of Healthcare stocks and 8% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 29, technicals 49.

Among the fundamentals, Price Target at 100 and Current Ratio at 99 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 46 and contrarian oscillators 57.

News sentiment is neutral at 57; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 31 to 44, and it is down 10 points over the period.

About OPKO Health

OPKO Health (OPK) is a healthcare company with pharmaceutical and diagnostics businesses. Its pharmaceutical products include Rayaldee, an extended-release vitamin D prohormone for secondary hyperparathyroidism in adults with chronic kidney disease, and NGENLA, a once-weekly growth hormone developed by OPKO and commercialized by Pfizer, with OPKO sharing in its economics. The company also sells pharmaceutical products through operations outside the United States and earns royalties under agreements with partners. Through its ModeX Therapeutics subsidiary, OPKO develops multispecific antibodies and vaccines for cancer and infectious diseases, in some cases with larger drug company partners such as Regeneron. Its diagnostics business, BioReference Health, provides laboratory testing and offers the 4Kscore test for prostate cancer risk. OPKO has been selling its BioReference diagnostic operations to Labcorp in stages.

OPKO competes with growth hormone makers such as Novo Nordisk and Ascendis Pharma, with other treatments for kidney disease complications and, in diagnostics, with large laboratories such as Quest Diagnostics. Its edge rests on a portfolio that combines marketed products, partner royalties and an early-stage drug development platform. Investors who follow OPK stock tend to watch Rayaldee sales and NGENLA results reported through its partnership with Pfizer. Progress at ModeX and its partnership milestones is closely followed. The exit from diagnostics, cash use, debt and share buybacks are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward OPK’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

29

Pulling it up

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Net income growth against the same quarter a year earlier, weighted toward the latest quarter.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

51

Pulling it up

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
57

Technical score by timeframe

ChartScoreWeight
Hourly361
Daily513
Weekly632
Monthly462
Quarterly412

Composite score, last 90 days

05010033Aug 23, 2026Nov 20, 2026Aug 23, 2026: 43Aug 25, 2026: 41Aug 26, 2026: 41Aug 27, 2026: 42Aug 28, 2026: 42Aug 29, 2026: 41Aug 31, 2026: 40Sep 1, 2026: 43Sep 2, 2026: 44Sep 4, 2026: 44Sep 5, 2026: 44Sep 6, 2026: 44Sep 8, 2026: 43Sep 9, 2026: 42Sep 10, 2026: 40Sep 11, 2026: 43Sep 12, 2026: 43Sep 13, 2026: 43Sep 15, 2026: 42Sep 17, 2026: 42Sep 18, 2026: 44Sep 19, 2026: 44Sep 20, 2026: 44Sep 21, 2026: 44Sep 23, 2026: 44Sep 24, 2026: 43Sep 25, 2026: 42Sep 26, 2026: 42Sep 27, 2026: 42Sep 28, 2026: 41Sep 29, 2026: 41Sep 30, 2026: 41Oct 1, 2026: 40Oct 2, 2026: 40Oct 3, 2026: 40Oct 4, 2026: 40Oct 6, 2026: 40Oct 7, 2026: 38Oct 8, 2026: 33Oct 9, 2026: 33Oct 10, 2026: 33Oct 11, 2026: 33Oct 13, 2026: 34Oct 14, 2026: 31Oct 15, 2026: 33Oct 16, 2026: 44Oct 17, 2026: 42Oct 18, 2026: 42Oct 19, 2026: 42Oct 21, 2026: 42Oct 22, 2026: 41Oct 23, 2026: 42Oct 24, 2026: 42Oct 25, 2026: 42Oct 27, 2026: 42Oct 28, 2026: 42Oct 29, 2026: 42Oct 30, 2026: 42Nov 1, 2026: 43Nov 3, 2026: 44Nov 4, 2026: 44Nov 5, 2026: 43Nov 6, 2026: 43Nov 7, 2026: 44Nov 11, 2026: 40Nov 12, 2026: 41Nov 13, 2026: 32Nov 14, 2026: 33Nov 15, 2026: 33Nov 18, 2026: 32Nov 19, 2026: 33Nov 20, 2026: 33
Show the daily numbers
DateComposite
Nov 20, 202633
Nov 19, 202633
Nov 18, 202632
Nov 15, 202633
Nov 14, 202633
Nov 13, 202632
Nov 12, 202641
Nov 11, 202640
Nov 7, 202644
Nov 6, 202643
Nov 5, 202643
Nov 4, 202644
Nov 3, 202644
Nov 1, 202643
Oct 30, 202642
Oct 29, 202642
Oct 28, 202642
Oct 27, 202642
Oct 25, 202642
Oct 24, 202642
Oct 23, 202642
Oct 22, 202641
Oct 21, 202642
Oct 19, 202642
Oct 18, 202642
Oct 17, 202642
Oct 16, 202644
Oct 15, 202633
Oct 14, 202631
Oct 13, 202634
Oct 11, 202633
Oct 10, 202633
Oct 9, 202633
Oct 8, 202633
Oct 7, 202638
Oct 6, 202640
Oct 4, 202640
Oct 3, 202640
Oct 2, 202640
Oct 1, 202640
Sep 30, 202641
Sep 29, 202641
Sep 28, 202641
Sep 27, 202642
Sep 26, 202642
Sep 25, 202642
Sep 24, 202643
Sep 23, 202644
Sep 21, 202644
Sep 20, 202644
Sep 19, 202644
Sep 18, 202644
Sep 17, 202642
Sep 15, 202642
Sep 13, 202643
Sep 12, 202643
Sep 11, 202643
Sep 10, 202640
Sep 9, 202642
Sep 8, 202643
Sep 6, 202644
Sep 5, 202644
Sep 4, 202644
Sep 2, 202644
Sep 1, 202643
Aug 31, 202640
Aug 29, 202641
Aug 28, 202642
Aug 27, 202642
Aug 26, 202641
Aug 25, 202641
Aug 23, 202643

Key facts

Market cap
$1.2B
Sector
Healthcare
Industry
Diagnostics & Research
Beta
1.53
Risk grade (1–10)
7
Next earnings
Nov 4, 2026

Questions

What is OPK's stock rating today?

OPK scores 33/100 (Bearish) as of Nov 19, 2026: technical 49, fundamental 29, and news sentiment 57, which is shown but not counted. Scores are recomputed every night.

What does OPKO Health do?

OPKO Health (OPK) is a healthcare company with pharmaceutical and diagnostics businesses. Its pharmaceutical products include Rayaldee, an extended-release vitamin D prohormone for secondary hyperparathyroidism in adults with chronic kidney disease, and NGENLA, a once-weekly growth hormone developed by OPKO and commercialized by Pfizer, with OPKO sharing in its economics.

Is OPK stock a buy?

The score is not a buy or sell recommendation. A 33 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the OPK score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

OPK stock score

HTML

<a href="https://stocksscores.com/stocks/opk/"><img src="https://stocksscores.com/stocks/opk/badge.svg" alt="OPK stock score" height="20"></a>

Markdown

[![OPK stock score](https://stocksscores.com/stocks/opk/badge.svg)](https://stocksscores.com/stocks/opk/)